During the last session, Oragenics Inc (AMEX:OGEN)’s traded shares were 0.56 million, with the beta value of the company hitting 0.46. At the end of the trading day, the stock’s price was $0.35, reflecting an intraday loss of -8.29% or -$0.04. The company’s market capitalization is $3.07M, and the average intraday trading volume over the past 10 days was 0.34 million shares, and the average trade volume was 732.98K shares over the past three months.
Oragenics Inc (AMEX:OGEN) trade information
Oragenics Inc (OGEN) registered a -8.29% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -8.29% in intraday trading to $0.35, hitting a weekly high. The stock’s 5-day price performance is -15.50%, and it has moved by -29.02% in 30 days. Based on these gigs, the overall price performance for the year is -89.74%. The short interest in Oragenics Inc (AMEX:OGEN) is 0.12 million shares and it means that shorts have 0.25 day(s) to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Oragenics Inc (OGEN) estimates and forecasts
In the rating firms’ projections, revenue will decrease -71.20% compared to the previous financial year.
As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 30k and 86k respectively.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 29.34%.
OGEN Dividends
Oragenics Inc is due to release its next quarterly earnings on 2023-May-12. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Oragenics Inc (AMEX:OGEN)’s Major holders
Oragenics Inc insiders own 12.02% of total outstanding shares while institutional holders control 14.01%, with the float percentage being 15.92%.
